BR9808227A - Preparação medicinal contendo gás inerte lipofìlico - Google Patents

Preparação medicinal contendo gás inerte lipofìlico

Info

Publication number
BR9808227A
BR9808227A BR9808227-2A BR9808227A BR9808227A BR 9808227 A BR9808227 A BR 9808227A BR 9808227 A BR9808227 A BR 9808227A BR 9808227 A BR9808227 A BR 9808227A
Authority
BR
Brazil
Prior art keywords
preparation containing
inert gas
medicinal preparation
containing lipophilic
lipophilic inert
Prior art date
Application number
BR9808227-2A
Other languages
English (en)
Inventor
Michael Georgieff
Original Assignee
Michael Georgieff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Georgieff filed Critical Michael Georgieff
Publication of BR9808227A publication Critical patent/BR9808227A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A61M16/0841—Joints or connectors for sampling
    • A61M16/085—Gas sampling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A61M2230/437—Composition of exhalation the anaesthetic agent concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"PREPARAçãO MEDICINAL CONTENDO GáS INERTE LIPOFìLICO"<D>. Uma preparação é descrita a qual contém um gás lipofílico com uma ação farmacológica em forma dissolvida ou dispersa. Esta preparação é particularmente adequada para a indução de anestesia.
BR9808227-2A 1997-03-10 1998-03-06 Preparação medicinal contendo gás inerte lipofìlico BR9808227A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19709704A DE19709704C2 (de) 1997-03-10 1997-03-10 Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
EP97113757A EP0864329B1 (de) 1997-03-10 1997-08-08 Medizinische Präparation, die ein lipophiles Edelgas enthält
PCT/EP1998/001304 WO1998040083A1 (en) 1997-03-10 1998-03-06 Medicinal preparation containing a lipophilic inert gas

Publications (1)

Publication Number Publication Date
BR9808227A true BR9808227A (pt) 2000-05-16

Family

ID=7822782

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808227-2A BR9808227A (pt) 1997-03-10 1998-03-06 Preparação medicinal contendo gás inerte lipofìlico

Country Status (33)

Country Link
US (3) US6328708B1 (pt)
EP (3) EP0864328B1 (pt)
JP (1) JPH10251142A (pt)
KR (2) KR20000076117A (pt)
CN (1) CN1104901C (pt)
AP (1) AP1162A (pt)
AT (3) ATE198047T1 (pt)
AU (1) AU738946C (pt)
BG (1) BG64583B1 (pt)
BR (1) BR9808227A (pt)
CA (1) CA2283227A1 (pt)
CZ (1) CZ292767B6 (pt)
DE (4) DE19709704C2 (pt)
DK (2) DK0864329T3 (pt)
EE (1) EE03807B1 (pt)
ES (2) ES2152608T3 (pt)
GR (1) GR3035553T3 (pt)
HK (1) HK1028335A1 (pt)
HU (1) HU224985B1 (pt)
ID (1) ID23151A (pt)
IL (1) IL131557A (pt)
NO (1) NO994091L (pt)
NZ (1) NZ337534A (pt)
OA (1) OA11156A (pt)
PL (1) PL189841B1 (pt)
PT (2) PT864329E (pt)
RU (1) RU2204397C2 (pt)
SI (1) SI0966291T1 (pt)
SK (1) SK284249B6 (pt)
TR (1) TR199902205T2 (pt)
TW (2) TWI241914B (pt)
WO (2) WO1998040084A1 (pt)
ZA (2) ZA981958B (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
AU750050B2 (en) * 1998-06-03 2002-07-11 Scott Laboratories, Inc. Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
DK1105096T3 (da) * 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
DE19851604A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Injektionsanästhesiemittel mit hydrophiler Phase
DE19851605A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Mikropartikel enthaltendes Injektionsanästhesiemittel
DE19852472A1 (de) * 1998-11-13 2000-05-25 Messer Griesheim Gmbh Analyse von mit Gasen beladenen Flüssigkeiten
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
AU5985900A (en) * 1999-07-19 2001-02-05 Michael Georgieff Novel spinal and epidural anaesthetic
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
US20050037374A1 (en) * 1999-11-08 2005-02-17 Melker Richard J. Combined nanotechnology and sensor technologies for simultaneous diagnosis and treatment
US20050233459A1 (en) * 2003-11-26 2005-10-20 Melker Richard J Marker detection method and apparatus to monitor drug compliance
CA2390261C (en) 1999-11-08 2014-04-22 University Of Florida Research Foundation, Inc. Marker detection method and apparatus to monitor drug compliance
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
DE10045845A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Xenon als Arzneimittel
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
US7104963B2 (en) * 2002-01-22 2006-09-12 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring intravenous (IV) drug concentration using exhaled breath
US6981947B2 (en) * 2002-01-22 2006-01-03 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring respiratory gases during anesthesia
AU2002220881A1 (en) * 2000-12-04 2002-06-18 Uws Ventures Limited Noble gas complexes
US7052854B2 (en) * 2001-05-23 2006-05-30 University Of Florida Research Foundation, Inc. Application of nanotechnology and sensor technologies for ex-vivo diagnostics
EP1405067A2 (en) * 2001-05-23 2004-04-07 University Of Florida Method and apparatus for detecting illicit substances
EP1393069A1 (en) * 2001-05-24 2004-03-03 The University Of Florida Method and apparatus for detecting environmental smoke exposure
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8567393B2 (en) * 2001-11-01 2013-10-29 Scott Laboratories, Inc User interface for sedation and analgesia delivery systems and methods
US20070167853A1 (en) * 2002-01-22 2007-07-19 Melker Richard J System and method for monitoring health using exhaled breath
DE10205056A1 (de) * 2002-02-07 2003-08-14 Hartwin Hobler Gesteuerte Mischung von Fluids für medizinische und biologische Anwendungen
GB0209998D0 (en) † 2002-05-01 2002-06-12 Protexeon Ltd Use
JP4657711B2 (ja) * 2002-05-16 2011-03-23 スコット・ラボラトリーズ・インコーポレイテッド 患者に鎮静および鎮痛を提供するシステム
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
CN1668316A (zh) * 2002-06-12 2005-09-14 梅瑟·格里斯海姆有限公司 含氙的解痉药
ATE420650T1 (de) 2002-06-12 2009-01-15 Air Liquide Deutschland Gmbh Cerebrale protektion mit einem xenonhaltigen gas
EP1521598A1 (de) * 2002-07-05 2005-04-13 Air Liquide Deutschland GmbH Xenon enthaltendes adjuvans
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
WO2004030525A2 (en) * 2002-10-03 2004-04-15 Scott Laboratories, Inc. Systems and methods for providing trend analysis in a sedation and analgesia system
US20060160134A1 (en) * 2002-10-21 2006-07-20 Melker Richard J Novel application of biosensors for diagnosis and treatment of disease
WO2004052337A2 (de) * 2002-12-06 2004-06-24 Michael Georgieff Nasale pharmazeutische präparation enthaltend eine lipophile flüssige oder gasförmige wirksubstanz
EP1610681B1 (en) * 2003-01-23 2011-10-05 University of Florida Research Foundation, Incorporated Method and apparatus for monitoring intravenous (iv) drug concentration using exhaled breath
JP4880466B2 (ja) * 2003-10-10 2012-02-22 プロテクソン リミテッド 新生児仮死を治療するための低体温療法におけるキセノンの使用
JP2007509091A (ja) * 2003-10-21 2007-04-12 エイジーエイ、アクティエボラーグ プログラム細胞死の防止のためのキセノンの使用
US20050191757A1 (en) * 2004-01-20 2005-09-01 Melker Richard J. Method and apparatus for detecting humans and human remains
US20060062734A1 (en) * 2004-09-20 2006-03-23 Melker Richard J Methods and systems for preventing diversion of prescription drugs
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060257883A1 (en) * 2005-05-10 2006-11-16 Bjoraker David G Detection and measurement of hematological parameters characterizing cellular blood components
US7914460B2 (en) 2006-08-15 2011-03-29 University Of Florida Research Foundation, Inc. Condensate glucose analyzer
AU2014277860A1 (en) * 2008-01-22 2015-01-22 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
US20110159078A1 (en) 2008-01-22 2011-06-30 Vapogenix, Inc Volatile Anesthetic Compositions and Methods of Use
WO2010033439A2 (en) * 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Anesthesia simulator and controller for closed-loop anesthesia
AU2010245932B2 (en) * 2009-05-05 2015-08-06 Board Of Regents, The University Of Texas System Novel formulations of volatile anesthetics and methods of use for reducing inflammation
US9278048B2 (en) 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
KR101656121B1 (ko) 2010-03-17 2016-09-08 노바리크 게엠베하 안압 증가를 치료하기 위한 약학 조성물
CN101928636B (zh) * 2010-09-08 2012-11-14 营口艾特科技有限公司 含氙气的油脂类液体及其制备方法
CN101961051A (zh) * 2010-09-08 2011-02-02 营口艾特科技有限公司 含氙气的液体及其制备方法
CN101940538B (zh) * 2010-09-08 2012-07-04 营口艾特科技有限公司 含氙气的化妆品及其制备方法
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
JP6073244B2 (ja) * 2011-01-04 2017-02-01 ノバリック ゲーエムベーハー 部分フッ素化アルカンを含むｏ／ｗエマルション
AU2012260787B2 (en) 2011-05-25 2017-02-02 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
RU2475249C1 (ru) * 2011-10-05 2013-02-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Средство для наружной терапии хронических рецидивирующих воспалительных заболеваний кожи
EP2806886B1 (en) 2012-01-23 2017-03-01 Novaliq GmbH Stabilised protein compositions based on semifluorinated alkanes
DE102012203897B4 (de) 2012-03-13 2014-11-27 Kist Europe Forschungsgesellschaft Mbh Vorrichtung zur Durchführung einer Anästhesie oder Analgosedierung und Verfahren zum Betreiben einer Vorrichtung zur Durchführung einer Anästhesie oder Analgosedierung
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
CN104755073B (zh) 2012-09-12 2017-12-26 诺瓦利克有限责任公司 半氟化烷烃组合物
CA2883002C (en) 2012-09-12 2019-05-21 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
AU2014233018A1 (en) * 2013-03-15 2015-10-01 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
KR101545706B1 (ko) * 2013-05-10 2015-08-26 주식회사 아미팜 포스파티딜콜린을 포함하는 지방 분해용 조성물 및 이의 제조방법
CN105555311B (zh) 2013-07-23 2021-10-08 诺瓦利克有限责任公司 稳定的抗体组合物
US20150328073A1 (en) * 2014-05-19 2015-11-19 Joseph Gerard Archer Hyperbaric Social Establishment or Residence
US10499838B2 (en) * 2015-04-24 2019-12-10 Drexel University Non-invasive brain water monitoring device for cerebral edema and cerebral autoregulation monitoring system and method
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
JP6642935B2 (ja) 2015-09-30 2020-02-12 ノバリック ゲーエムベーハー 眼投与用の半フッ素化化合物
PL3442480T3 (pl) 2016-06-23 2020-04-30 Novaliq Gmbh Sposób podawania miejscowego
CN109890374A (zh) 2016-09-22 2019-06-14 诺瓦利克有限责任公司 用于治疗睑缘炎的药物组合物
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
BR112019021917A8 (pt) 2017-04-21 2023-03-21 Novaliq Gmbh Composições de iodo
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
BR112020006072A2 (pt) 2017-09-27 2020-10-06 Novaliq Gmbh composições oftalmáticas compreendendo latanoprost para uso no tratamento de doenças oculares
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
WO2019166631A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
WO2020074697A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
CN113811950A (zh) * 2018-12-14 2021-12-17 派尔疗法股份有限公司 优化含丁丙诺啡的产品的诱导的数字治疗组件
EP3839959A1 (en) * 2019-12-19 2021-06-23 Koninklijke Philips N.V. Transdermal sedative release control in autonomous imaging

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL139241B (nl) * 1967-01-09 Mallinckrodt Chemical Works Werkwijze voor het bereiden en afvoeren van een farmaceutisch aanvaardbare, een radioactief gas bevattende zoutoplossing, alsmede gevulde eenheidspatroon verkregen door toepassing van deze werkwijze.
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
GR64915B (en) * 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US5140981A (en) 1986-11-24 1992-08-25 Picker International, Inc. End-tidal gas detection
SE8700977D0 (sv) * 1987-03-09 1987-03-09 Olof Werner Enhet som i olika grad separerar gasinnehallet i drivkrets och mottagarkrets, men som enda tillater gasgenomslepp i bada riktningarna (oppen separation)
US4781698A (en) * 1987-04-09 1988-11-01 Parren Mark L Selectable drop size infusion metering device
DE3712598A1 (de) * 1987-04-14 1988-10-27 Siemens Ag Inhalations-anaesthesiegeraet
DE3828905A1 (de) * 1988-08-23 1990-03-15 Schering Ag Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
DE3940389A1 (de) * 1989-12-06 1991-06-13 Abolghassem Prof Dr M Pakdaman Therapeutisches mittel
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5088499A (en) 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5320093A (en) 1990-12-21 1994-06-14 Brigham And Women's Hospital Rapid anesthesia emergence system using closed-loop PCO2 control
DE4100782A1 (de) * 1991-01-12 1992-07-16 Patentverwertung Dr J Haensler Waessrige ozonpraeparate, verfahren zu ihrer herstellung und ihre verwendung
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
DE4411533C1 (de) * 1994-04-02 1995-04-06 Draegerwerk Ag Anästhesiegerät
US5545396A (en) * 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US5780010A (en) 1995-06-08 1998-07-14 Barnes-Jewish Hospital Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US5807321A (en) * 1995-11-28 1998-09-15 Merit Medical System for electronically monitoring the delivery of contrast media
SE9601348D0 (sv) * 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
SE9601719D0 (sv) * 1996-05-06 1996-05-06 Siemens Elema Ab Doserare för tillförsel av tillsatsgas eller vätska till andningsgas vid anestesiapparat eller ventilator
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie

Also Published As

Publication number Publication date
KR100504287B1 (ko) 2005-07-28
SI0966291T1 (en) 2002-04-30
BG103712A (en) 2000-04-28
ES2152608T3 (es) 2001-02-01
PT864329E (pt) 2001-03-30
ATE198047T1 (de) 2000-12-15
ATE207754T1 (de) 2001-11-15
EP0966291B1 (en) 2001-10-31
ES2162437T3 (es) 2001-12-16
CA2283227A1 (en) 1998-09-17
US6197323B1 (en) 2001-03-06
DE59709351D1 (de) 2003-03-27
KR20000076117A (ko) 2000-12-26
EP0864328B1 (de) 2003-02-19
DE59702760D1 (de) 2001-01-18
PL189841B1 (pl) 2005-09-30
SK118799A3 (en) 2000-05-16
WO1998040083A1 (en) 1998-09-17
AP9901630A0 (en) 1999-09-30
EP0864329A1 (de) 1998-09-16
CN1255065A (zh) 2000-05-31
DE69802268T2 (de) 2002-05-16
CZ317399A3 (cs) 2000-01-12
PL335444A1 (en) 2000-04-25
EP0864328A1 (de) 1998-09-16
NO994091L (no) 1999-10-27
AU6828698A (en) 1998-09-29
KR20000076077A (ko) 2000-12-26
TW396040B (en) 2000-07-01
US20020052573A1 (en) 2002-05-02
HUP0001510A3 (en) 2000-12-28
ID23151A (id) 2000-03-23
NZ337534A (en) 2001-02-23
AU738946B2 (en) 2001-09-27
EP0864329B1 (de) 2000-12-13
CN1104901C (zh) 2003-04-09
GR3035553T3 (en) 2001-06-29
DE69802268D1 (de) 2001-12-06
US6328708B1 (en) 2001-12-11
EE03807B1 (et) 2002-08-15
TR199902205T2 (xx) 1999-12-21
DE19709704C2 (de) 1999-11-04
PT966291E (pt) 2002-03-28
ZA981953B (en) 1999-09-09
SK284249B6 (sk) 2004-12-01
ZA981958B (en) 1999-09-09
HU224985B1 (en) 2006-05-29
EP0966291A1 (en) 1999-12-29
CZ292767B6 (cs) 2003-12-17
WO1998040084A1 (en) 1998-09-17
TWI241914B (en) 2005-10-21
AP1162A (en) 2003-06-30
JPH10251142A (ja) 1998-09-22
DE19709704A1 (de) 1998-09-24
EE9900399A (et) 2000-04-17
AU738946C (en) 2002-05-02
RU2204397C2 (ru) 2003-05-20
NO994091D0 (no) 1999-08-24
DK0864329T3 (da) 2001-04-09
OA11156A (en) 2003-04-22
HK1028335A1 (en) 2001-02-16
IL131557A (en) 2004-06-20
US6511453B2 (en) 2003-01-28
HUP0001510A2 (hu) 2000-09-28
ATE232735T1 (de) 2003-03-15
BG64583B1 (bg) 2005-08-31
DK0966291T3 (da) 2002-02-25

Similar Documents

Publication Publication Date Title
BR9808227A (pt) Preparação medicinal contendo gás inerte lipofìlico
BR9915755A (pt) Anti-inflamátorio não-esteroidal
BR9907647A (pt) Composições contendo composto orgânicos
BR9710496A (pt) Sistema de montagem de escora para implantes dentários.
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BR9906888A (pt) &#34;travessa&#34;
ES2178298T3 (es) Compuestos anti-inflamatorios.
BR9808348A (pt) Alimento medicinal para diabéticos
BR9908488A (pt) Composição farmacêutica de topiramato
BR9914978A (pt) Estabilização de produtos de cuidados do corpo e domésticos
HUP9903823A3 (en) Use of sibutramine analogues for the preparation of pharmaceutical compositions suitable for lowering lipid levels
BR9913457A (pt) Neuroproteção
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR9807655A (pt) Uso de inibidores de lipase gastrintestinal.
BR9813817A (pt) Análogos de hemiasterlina
BR9811458A (pt) &#34;sistema solvente para penetração melhorada de compostos farmacêuticos&#34;
BR9801120A (pt) Formulações de rapamicina para administração oral.
BR9807471A (pt) Uso do composto anti-cd40l
ZA981780B (en) The use of levobupivacaine in paediatric surgery
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
PT979116E (pt) Aparelho para administracao de medicamentos atraves de inalacao
BR9811643A (pt) Suplementação quìmica de osso
BR0006269A (pt) Aplicação de dialquilpolissulfetos para o amassamento de borrachas naturais e de sìntese
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR9807265A (pt) Processo de epoxidação seletiva para preparação de compostos farmacêuticos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI ( LEI 9279/96 ) 2O , O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAOPATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.